31
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis

, , , , , , , , , , , & show all
Pages 1237-1247 | Published online: 15 Feb 2019

References

  • FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
  • FanSTPoonRTYeungCOutcome after partial hepatectomy for hepatocellular cancer within the Milan criteriaBr J Surg20119891292130021656513
  • ColecchiaASchiumeriniRCucchettiAPrognostic factors for hepatocellular carcinoma recurrenceWorld J Gastroenterol20142020593524876717
  • FanSTMau LoCPoonRTContinuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experienceAnn Surg2011253474575821475015
  • QuencerKBFriedmanTShethROkluRTumor thrombus: incidence, imaging, prognosis and treatmentCardiovasc Diagn Ther20177Suppl 3S165S17729399520
  • Rodríguez-PerálvarezMLuongTVAndreanaLMeyerTDhillonAPBurroughsAKA systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variabilityAnn Surg Oncol201320132533923149850
  • HirokawaFHayashiMAsakumaMShimizuTInoueYUchiyamaKRisk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinomaSurg Oncol2016251242926979637
  • BruixJLlovetJMMajor achievements in hepatocellular carcinomaLancet2009373966461461619231618
  • RoayaieSBlumeINThungSNA system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinomaGastroenterology2009137385085519524573
  • DuMChenLZhaoJMicrovascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinomaBMC Cancer2014143824460749
  • LimKCChowPKAllenJCMicrovascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteriaAnn Surg2011254110811321527845
  • YeJZChenJZLiZHEfficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasionWorld J Gastroenterol201723417415742429151695
  • SunJJWangKZhangCZPostoperative adjuvant transcatheter arterial chemoembolization after R0 hepatectomy improves outcomes of patients who have hepatocellular carcinoma with microvascular invasionAnn Surg Oncol20162341344135126714945
  • WangLWangWYaoXPostoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasionOncotarget2017845799717998129108379
  • YuWWangWRongWAdjuvant radiotherapy in centrally located hepatocellular carcinomas after hepatectomy with narrow marginJ Am Coll Surg2014218338139224559953
  • KornRLCrowleyJJOverview: progression-free survival as an endpoint in clinical trials with solid tumorsClin Cancer Res201319102607261223669420
  • CongWMBuHChenJPractice guidelines for the pathological diagnosis of primary liver cancer: 2015 updateWorld J Gastroenterol201622429279928727895416
  • SeldingerSICatheter replacement of the needle in percutaneous arteriography; a new techniqueActa Radiol195339536837613057644
  • BrookhartMASchneeweissSRothmanKJGlynnRJAvornJStürmerTVariable selection for propensity score modelsAm J Epidemiol2006163121149115616624967
  • AustinPCAn introduction to propensity score methods for reducing the effects of confounding in observational studiesMultivariate Behav Res201146339942421818162
  • AndreouAAVautheyJ-NCherquiDImproved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomyJ Gastrointest Surg2013171667722948836
  • BarretoSGBrooke-SmithMDolanPWilsonTGPadburyRTAChenJWCCirrhosis and microvascular invasion predict outcomes in hepatocellular carcinoma: outcomes of hepatocellular carcinomaANZ J Surg201383533133522943449
  • MoonJIKwonCHJohJWPrimary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survivalTransplant Proc201244248749322410053
  • FanLFZhaoWCYangNYangGSAlpha-fetoprotein: the predictor of microvascular invasion in solitary small hepatocellular carcinoma and criterion for anatomic or non-anatomic hepatic resectionHepatogastroenterology20136012482583623321029
  • McHughPPGilbertJVeraSKochARanjanDGedalyRAlpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepato-cellular carcinomaHPB (Oxford)2010121566120495646
  • ZhaoWCFanLFYangNZhangHBChenBDYangGSPreoperative predictors of microvascular invasion in multinodular hepatocellular carcinomaEur J Surg Oncol201339885886423669199
  • ToyosakaAOkamotoEMitsunobuMOriyamaTNakaoNMiuraKPathologic and radiographic studies of intrahepatic metastasis in hepatocel-lular carcinoma; the role of efferent vesselsHPB Surg1996102971049184864
  • SumieSNakashimaOOkudaKThe significance of classifying microvascular invasion in patients with hepatocellular carcinomaAnn Surg Oncol20142131002100924254204
  • ShiMZhangCQZhangYQLiangXMLiJQMicrometastases of solitary hepatocellular carcinoma and appropriate resection marginWorld J Surg200428437638115022021
  • HuRHLeePHChangYCHoMCYuSCTreatment of centrally located hepatocellular carcinoma with central hepatectomySurgery2003133325125612660635
  • HirokawaFHayashiMMiyamotoYOutcomes and predictors of microvascular invasion of solitary hepatocellular carcinomaHepatol Res201444884685323834279
  • IkaiIAriiSKojiroMReevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide surveyCancer2004101479680215305412
  • ShiMGuoRPLinXJPartial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trialAnn Surg20072451364317197963
  • ShimadaKSakamotoYEsakiMKosugeTRole of the width of the surgical margin in a hepatectomy for small hepatocellular carcinomas eligible for percutaneous local ablative therapyAm J Surg2008195677578118440487
  • MatsuiYTerakawaNSatoiSPostoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: clinical role of the no-margin resectionArch Surg Chic Ill 196020071427596602
  • MorisDTsilimigrasDIKostakisIDAnatomic versus non-anatomic resection for hepatocellular carcinoma: a systematic review and meta-analysisEur J Surg Oncol201844792793829751946
  • ZhongCGuoRPLiJQA randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for stage III a hepatocellular carcinomaJ Cancer Res Clin Oncol2009135101437144519408012
  • PengBGHeQLiJPZhouFAdjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombusAm J Surg2009198331331819285298
  • KobayashiTIshiyamaKOhdanHPrevention of recurrence after curative treatment for hepatocellular carcinomaSurg Today201343121347135423271667
  • ZhongJ-HDuX-KXiangB-DLiL-QAdjuvant sorafenib in hepatocellular carcinoma: a cautionary Comment of storm trialWorld J Hepatol201682395796027621761
  • JengWJLinCCChenWTSheenISLinCYLinSMAdjuvant therapy for hepatocellular carcinoma after curative treatmentDig Dis201432674775425376293
  • LeiJZhongJHaoJHepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrenceOncotarget2016727425984260726981887
  • ChengSHLinYMChuangVPA pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinomaJ Gastroenterol Hepatol199914101025103310530500
  • KimJYChungSMChoiBOKayCSHepatocellular carcinoma with portal vein tumor thrombosis: improved treatment outcomes with external beam radiation therapyHepatol Res201141981382421696524
  • WangWHWangZWuJXSurvival benefit with IMRT following narrow-margin hepatectomy in patients with hepatocellular carcinoma close to major vesselsLiver Int201535122603261025939444
  • TongYLiZLiangYPostoperative adjuvant TACE for patients of hepatocellular carcinoma in AJCC stage I: friend or foe? A propensity score analysisOncotarget2017816266712667828460456
  • ChenXZhangBQiuSEffect of postoperative adjuvant transarterial chemoembolization on late recurrence of hepatocellular carcinoma after radical resectionZhonghua Gan Zang Bing Za Zhi201018859960320825715
  • ChengXSunPHuQGSongZFXiongJZhengQCTransarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analysesJ Cancer Res Clin Oncol201414071159117024752339
  • LiaoMZhuZWangHHuangJAdjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysisScand J Gastroenterol2017526–762463428276833
  • SainaniKLPropensity scores: uses and limitationsPM&R20124969369722980422
  • OkoliGNSandersRDMylesPDemystifying propensity scoresBr J Anaesth20141121131524318697